BioVie
BIVI
48 hedge funds and large institutions have $1.79M invested in BioVie in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 0.12% → 0.07% (-0.05%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
2% less funds holding
Funds holding: 49 → 48 (-1)
13% less call options, than puts
Call options by funds: $14K | Put options by funds: $16K
50% less capital invested
Capital invested by funds: $3.55M → $1.79M (-$1.76M)
59% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$84.3K |
| 2 |
Goldman Sachs
New York
|
+$29.5K |
| 3 |
VF
Virtu Financial
New York
|
+$21.3K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$21.1K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$17.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$493K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$317K |
| 3 |
Renaissance Technologies
New York
|
-$184K |
| 4 |
BlackRock
New York
|
-$147K |
| 5 |
State Street
Boston,
Massachusetts
|
-$69.9K |
BIVI Hedge Fund Activity: Q2 2024 in Review
48 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q2 2024, worth a combined $1.79M — down 50% from $3.55M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of BIVI and 13 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 7 added.
The largest buyer was Jane Street, opening a new position worth an estimated $84.3K. The largest seller was Altium Capital Management, cutting an estimated $493K.
- 48 institutional investors held BioVie (BIVI) as of Q2 2024, down from 49 in Q1 2024.
- Funds reported $1.79M of BioVie stock for Q2 2024, down 50% quarter-over-quarter.
- 13 funds opened new BioVie positions in Q2 2024 and 14 closed out, a net change of -1 holder.
- The largest BioVie buyer in Q2 2024 was Jane Street, an estimated $84.3K added.
- The largest BioVie seller in Q2 2024 was Altium Capital Management, an estimated $493K sold.
Based on aggregated 13F filings for Q2 2024.